TerrAscend (OTCMKTS:TSNDF – Get Free Report) and GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, valuation, institutional ownership and analyst recommendations.
Risk and Volatility
TerrAscend has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Comparatively, GE HealthCare Technologies has a beta of 0.65, suggesting that its stock price is 35% less volatile than the S&P 500.
Analyst Ratings
This is a summary of recent ratings and price targets for TerrAscend and GE HealthCare Technologies, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| TerrAscend | 0 | 1 | 0 | 0 | 2.00 |
| GE HealthCare Technologies | 0 | 11 | 12 | 0 | 2.52 |
GE HealthCare Technologies has a consensus price target of $80.87, indicating a potential downside of 3.36%. Given GE HealthCare Technologies’ stronger consensus rating and higher possible upside, analysts plainly believe GE HealthCare Technologies is more favorable than TerrAscend.
Valuation and Earnings
This table compares TerrAscend and GE HealthCare Technologies”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| TerrAscend | $260.56 million | 0.54 | -$81.33 million | ($0.11) | -4.14 |
| GE HealthCare Technologies | $20.62 billion | 1.83 | $2.08 billion | $4.74 | 17.65 |
GE HealthCare Technologies has higher revenue and earnings than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than GE HealthCare Technologies, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
5.8% of TerrAscend shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 31.9% of TerrAscend shares are owned by insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Profitability
This table compares TerrAscend and GE HealthCare Technologies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| TerrAscend | -31.01% | -32.93% | -5.49% |
| GE HealthCare Technologies | 9.96% | 20.45% | 5.97% |
Summary
GE HealthCare Technologies beats TerrAscend on 12 of the 14 factors compared between the two stocks.
About TerrAscend
TerrAscend Corp. is a North American cannabis company that cultivates, processes, manufactures and sells cannabis products through a combination of wholesale and retail operations. Its product portfolio includes flower, pre-rolls, concentrates, vape products, edibles, tinctures, topicals and other cannabis-derived products. The company serves medical and adult-use cannabis markets in several U.S. states, including Pennsylvania, New Jersey, Maryland, Michigan, Ohio and California, as well as the Canadian market.
About GE HealthCare Technologies
GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.
Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.
